Unilever is looking to sell or de-emphasize its food & beverage units as it eyes the consumer healthcare division of GlaxoSmithKline, whose products include Advil pain reliever and Aquafresh and Sensodyne toothpaste.
The latest bid was reported at $68 billion, which would require Unilever to raise cash, which may prompt it to sell off its remaining food & beverage portfolio.
Unilever’s food & beverage products include Ben & Jerry’s ice cream and Hellman’s mayonnaise.
According to Unilever, its strategic direction lies in materially expanding its health, beauty, and hygiene businesses, which would require major acquisitions accompanied by the accelerated divestment of lower-growth brands and businesses.
Unilever had sold parts of its food and beverage businesses recently, including its spreads portfolio in 2017 and most of its tea business in 2020.
According to Unilever CEO Alan Jope, while its food and refreshments products are still profitable, its long-term growth profile has been below other parts of its portfolio.


Asian Stocks Mixed in March 2026 Amid Iran War Fears and Tech Selloff
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
WTO Ministerial Collapse Leaves Global Digital Trade Rules in Limbo
Oil Prices Climb as Middle East Conflict Keeps Supply Risks Elevated
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
South Korea's Exports Hit Record High in March on AI-Driven Chip Demand
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Australia Bans Card Payment Surcharges Starting October 2025
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Gold Prices Rebound in Asia Amid Iran War Ceasefire Hopes
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Oil Prices Surge to Record Monthly Highs as Middle East War Rattles Global Markets
Goldman Sachs Sees Value in European Real Estate Stocks Despite Sharp Selloff 



